82009-163 : Ustekinumab-ttwe-ttwe 130 mg/26ml Intravenous Injection, Solution


NDC: 82009-163
Labeler: Quallent Pharmaceuticals Health LLC
Product Type: Human Prescription Drug
Drug Name:  Ustekinumab-ttwe
Dosage Form: Intravenous Injection, Solution
Application #: BLA761425
Rev. Date: 


NDC Package Codes:

  • 82009-163-94: 1 VIAL, SINGLE‑USE IN 1 CARTON (82009‑163‑94) / 26 ML IN 1 VIAL, SINGLE‑USE

Active Ingredients:

  • Ustekinumab

Dosage Strength:

  • 130 mg/26mL

Pharmaceutical Classes:

  • Interleukin-12 Antagonist [EPC]
  • Interleukin-12 Antagonists [MoA]
  • Interleukin-23 Antagonist [EPC]
  • Interleukin-23 Antagonists [MoA]

Related Products:

Based on records with the same trade name.
  • 82009-160 Ustekinumab-ttwe-ttwe 45 mg/.5ml Subcutaneous Injection, Solution by Quallent Pharmaceuticals Health LLC
  • 82009-162 Ustekinumab-ttwe-ttwe 90 mg/ml Subcutaneous Injection, Solution by Quallent Pharmaceuticals Health LLC

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 82009-163 QR Code

< Prev: 82009-162Next: 82009-164 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.